Improved Infrastructure Supporting Investigational New Drug Clinical Studies Stressed

Published: 2004-12-23 06:59:00

Updated: 2004-12-23 06:59:00

While the number of Investigational New Drug (IND) applications has been steadily rising over the past few years, the necessary infrastructure for conducing their clinical studies is grossly inadequate as compared to the international standards, according to a report released by the Samsung Econo...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK